Jiaqiong Xu Selected Research

Jiaqiong Xu Research Topics

Disease

7	Neoplasms (Cancer) 03/2022 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 05/2009
2	Cholangiocarcinoma 01/2022 - 01/2022
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2022
2	COVID-19 06/2021 - 11/2020
2	Cardiotoxicity 01/2021 - 12/2019
2	Heart Failure 12/2019 - 08/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2015 - 12/2009
2	Albuminuria 03/2008 - 02/2007
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Klatskin Tumor 01/2022
1	Sepsis (Septicemia) 06/2021
1	Cytokine Release Syndrome 06/2021
1	Hemolysis 06/2021
1	Coronavirus Infections 06/2021
1	Second Primary Neoplasms (Neoplasms, Second) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Hepatitis B 01/2021
1	Multiple Myeloma 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Prolapse 12/2020
1	Critical Illness (Critically Ill) 11/2020
1	Chronic Disease (Chronic Diseases) 10/2020
1	Lung Neoplasms (Lung Cancer) 12/2019
1	Myocardial Infarction 12/2019
1	Stroke (Strokes) 12/2019
1	Thyroid Neoplasms (Thyroid Cancer) 02/2017
1	Papillary Thyroid Microcarcinoma 02/2017
1	Heart Diseases (Heart Disease) 03/2016
1	Fibrosis (Cirrhosis) 08/2014
1	Ischemia 12/2013
1	Bundle-Branch Block (Fascicular Block) 12/2013
1	Chest Pain (Chest Pains) 01/2013
1	Hypertension (High Blood Pressure) 10/2012
1	Prehypertension 10/2012
1	Monoclonal Gammopathy of Undetermined Significance 03/2012
1	Pathologic Constriction (Stenosis) 11/2011
1	Insulin Resistance 05/2008
1	Body Weight (Weight, Body) 08/2007
1	Coronary Disease (Coronary Heart Disease) 10/2006

Drug/Important Bio-Agent (IBA)

3	CreatinineIBA 05/2009 - 02/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2022
2	Gemcitabine FDA Link 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2021 - 12/2019
2	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 03/2008
2	omega-Chloroacetophenone (Mace)IBA 12/2019 - 01/2013
2	CalciumIBA 02/2015 - 11/2009
1	CarboxyhemoglobinIBA 06/2021
1	AnthracyclinesIBA 01/2021
1	atezolizumabIBA 01/2021
1	avelumabIBA 01/2021
1	durvalumabIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	IpilimumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	Insulin (Novolin)FDA Link 11/2020
1	Blood Glucose (Blood Sugar)IBA 11/2020
1	TroponinIBA 12/2019
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2017
1	Thyroglobulin FDA Link 02/2017
1	anti-thyroglobulinIBA 02/2017
1	Collagen Type III (Type III Collagen)IBA 08/2014
1	Spironolactone (Aldactone)FDA LinkGeneric 08/2014
1	Adenosine (Adenocard)FDA LinkGeneric 12/2013
1	regadenoson FDA Link 12/2013
1	LDL CholesterolIBA 10/2012
1	Proteins (Proteins, Gene)FDA Link 03/2012
1	Fish OilsIBA 12/2009
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2008
1	CarbohydratesIBA 05/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2008
1	Dietary CalciumIBA 08/2007
1	AlbuminsIBA 02/2007
1	Dietary Fats (Dietary Fat)IBA 10/2006

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 03/2022 - 01/2021
5	Therapeutics 01/2022 - 12/2019
2	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 01/2022
2	Liver Transplantation 01/2022 - 01/2022
1	Neoadjuvant Therapy 01/2022
1	Transplantation 01/2022
1	Metastasectomy 01/2022
1	Treatment Delay 01/2021
1	Suburethral Slings (Tension-Free Vaginal Tape) 12/2020
1	Art Therapy 10/2020
1	Immunotherapy 12/2019
1	Contraindications 03/2016
1	Prostheses and Implants (Prosthesis) 11/2011